| Tanespimycin studied in …STUDIED_INderived35 of 35show fewer |
|---|
| → studied in | NCT00118092Phase 2 · completed 17-AAG in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Previous Hormone Therapy · 35 trials list this drug (0 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00118248Phase 2 · completed Tanespimycin in Treating Patients With Inoperable Locoregionally Advanced or Metastatic Thyroid Cancer · 35 trials list this drug (0 active) | — | — | Thyroid Gland Follicular Carcinoma,Malignant Thyroid Gland Neoplasm,Thyroid Gland Medullary Carcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00096109Phase 2 · terminated Tanespimycin in Treating Women With Refractory Locally Advanced or Metastatic Breast Cancer · 35 trials list this drug (0 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00514371Phase 2/Phase 3 · completed A Study of Tanespimycin (KOS-953) in Patients With Relapsed-refractory Multiple Myeloma · 35 trials list this drug (0 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00773344Phase 1/Phase 2 · completed Clinical Trial of the Combination of Trastuzumab (Herceptin) and Tanespimycin in Patients With Solid Tumors and Her2 Positive Metastatic Breast Cancer That Have Previously Failed Herceptin · 35 trials list this drug (0 active) | — | — | Solid Neoplasm,Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00779428Phase 2 · completed Clinical Trial of Continuing Treatment for Patients Who Have Participated on a Prior Protocol Investigating Tanespimycin · 35 trials list this drug (0 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00577889Phase 2 · completed Gemcitabine Hydrochloride and Tanespimycin in Treating Patients With Stage IV Pancreatic Cancer · 35 trials list this drug (0 active) | — | — | Malignant Pancreatic Neoplasm,Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00058253Phase 1 · completed Combination Chemotherapy in Treating Patients With Metastatic or Unresectable Solid Tumors · 35 trials list this drug (0 active) | — | — | Adult Solid Neoplasm,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00121264Phase 1 · completed 17-AAG and Sorafenib in Treating Patients With Unresectable or Metastatic Solid Tumors · 35 trials list this drug (0 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00117988Phase 2 · completed 17-AAG in Treating Patients With Relapsed or Refractory Anaplastic Large Cell Lymphoma, Mantle Cell Lymphoma, or Hodgkin's Lymphoma · 35 trials list this drug (0 active) | — | — | Anaplastic Large Cell Lymphoma,Adult Hodgkin Lymphoma,Mantle Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00093496Phase 2 · completed Gemcitabine Hydrochloride and Tanespimycin in Treating Patients With Recurrent Advanced Ovarian Epithelial or Peritoneal Cavity Cancer · 35 trials list this drug (0 active) | — | — | Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00096005Phase 1 · terminated Tanespimycin and Bortezomib in Treating Patients With Advanced Solid Tumors or Lymphomas · 35 trials list this drug (0 active) | — | — | Adult Solid Neoplasm,Anaplastic Large Cell Lymphoma,Non-Hodgkin Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00019708Phase 1 · terminated Geldanamycin Analogue in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma · 35 trials list this drug (0 active) | — | — | Adult Solid Neoplasm,Non-Hodgkin Lymphoma,Adult Lymphoblastic Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00098423Phase 1 · completed Tanespimycin and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Chronic Myelomonocytic Leukemia, or Myelodysplastic Syndromes · 35 trials list this drug (0 active) | — | — | Myelodysplastic Syndrome,Secondary Acute Myeloid Leukemia,Adult Acute Lymphoblastic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00100997Phase 1 · completed 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Did Not Respond to Imatinib Mesylate · 35 trials list this drug (0 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003969Phase 1 · completed Geldanamycin Analogue in Treating Patients With Advanced Cancer · 35 trials list this drug (0 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00104897Phase 2 · completed 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic Malignant Melanoma · 35 trials list this drug (0 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004065Phase 1 · completed Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer · 35 trials list this drug (0 active) | — | — | Adult Solid Neoplasm,Leukemia,Malignant Breast Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00093405Phase 2 · completed 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic Kidney Cancer · 35 trials list this drug (0 active) | — | — | Malignant Kidney Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00079404Phase 1 · completed 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Young Patients With Relapsed or Refractory Solid Tumors or Leukemia · 35 trials list this drug (0 active) | — | — | Childhood Solid Neoplasm,Secondary Acute Myeloid Leukemia,Childhood Acute Lymphoblastic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00047047Phase 1 · completed Tanespimycin, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Advanced Solid Tumors · 35 trials list this drug (0 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00093821Phase 1 · completed Tanespimycin in Treating Young Patients With Recurrent or Refractory Leukemia or Solid Tumors · 35 trials list this drug (0 active) | — | — | Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,Osteosarcoma,Childhood Acute Lymphoblastic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00098488Phase 1 · terminated 17-N-Allylamino-17-Demethoxygeldanamycin With or Without Rituximab in Treating Patients With Relapsed B-Cell Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia · 35 trials list this drug (0 active) | — | — | Chronic Lymphocytic Leukemia,Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00103272Phase 1 · terminated 17-N-Allylamino-17-Demethoxygeldanamycin and Bortezomib in Treating Patients With Relapsed or Refractory Hematologic Cancer · 35 trials list this drug (0 active) | — | — | Anaplastic Large Cell Lymphoma,Adult Acute Lymphoblastic Leukemia,Adult T-Cell Leukemia/Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00119236Phase 1 · completed 17-AAG and Irinotecan in Treating Patients With Locally Advanced or Metastatic Solid Tumors · 35 trials list this drug (0 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00354185Phase 1 · terminated PXD101 and 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphoma · 35 trials list this drug (0 active) | — | — | Adult Solid Neoplasm,Anaplastic Large Cell Lymphoma,Non-Hodgkin Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00087386Phase 2 · terminated Tanespimycin in Treating Patients With Stage III-IV Melanoma · 35 trials list this drug (0 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00066326Phase 1 · completed Imatinib Mesylate and 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Chronic Myelogenous Leukemia · 35 trials list this drug (0 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004241Phase 1 · completed 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or Sarcoma · 35 trials list this drug (0 active) | — | — | Adult Solid Neoplasm,Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,Anaplastic Large Cell Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00087217Phase 1 · completed 17-N-Allylamino-17-Demethoxygeldanamycin and Paclitaxel in Treating Patients With Metastatic or Unresectable Solid Tumor · 35 trials list this drug (0 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00088374Phase 2 · completed 17AAG to Treat Kidney Tumors in Von Hippel-Lindau Disease · 35 trials list this drug (0 active) | — | — | Malignant Kidney Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00132015Phase 2 · completed 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Systemic Mastocytosis · 35 trials list this drug (0 active) | — | — | Leukemia,Lymphoma,Myeloproliferative Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004075Phase 1 · completed 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery · 35 trials list this drug (0 active) | — | — | Adult Solid Neoplasm,Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00546780Phase 3 · completed A Study of Tanespimycin (KOS-953) in Patients With Multiple Myeloma in First Relapse · 35 trials list this drug (0 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00319930Phase 1 · terminated Phase 1, Dose-Escalation, Pharmacodynamic Study of IV CNF1010 in ZAP-70 Positive CLL · 35 trials list this drug (0 active) | — | — | Chronic Lymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |